HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 92 filers reported holding HILLEVAX INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $30,230,134 | +1.0% | 2,090,604 | +16.1% | 0.00% | 0.0% |
| Q1 2024 | $29,938,606 | +5.0% | 1,800,277 | +1.4% | 0.00% | 0.0% |
| Q4 2023 | $28,503,790 | +64.6% | 1,775,937 | +37.9% | 0.00% | – |
| Q3 2023 | $17,317,979 | -20.7% | 1,287,582 | +1.3% | 0.00% | -100.0% |
| Q2 2023 | $21,839,414 | +27.3% | 1,270,472 | +22.4% | 0.00% | 0.0% |
| Q1 2023 | $17,155,612 | -0.3% | 1,037,847 | +0.9% | 0.00% | 0.0% |
| Q4 2022 | $17,206,353 | +30.4% | 1,028,473 | +33.2% | 0.00% | – |
| Q3 2022 | $13,193,000 | +63.7% | 772,054 | +4.7% | 0.00% | – |
| Q2 2022 | $8,058,000 | – | 737,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 558,923 | $8,082,027 | 15.36% |
| Catalys Pacific, LLC | 1,208,974 | $17,481,764 | 13.19% |
| Frazier Life Sciences Management, L.P. | 10,617,062 | $153,522,717 | 7.18% |
| Carlyle Group Inc. | 1,838,486 | $26,437,429 | 2.51% |
| StepStone Group LP | 826,569 | $11,952,188 | 2.42% |
| Samsara BioCapital, LLC | 799,274 | $11,557,502 | 2.42% |
| MPM BioImpact LLC | 645,085 | $9,327,929 | 1.45% |
| BRIDGER MANAGEMENT, LLC | 140,100 | $2,025,846 | 1.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,004,231 | $57,901,180 | 0.96% |
| Deep Track Capital, LP | 1,832,652 | $26,500,148 | 0.79% |